Celal Acar

Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers

İnci Alacacıoğlu, Güner Hayri Özsan, Bahriye Payzın et al. · Chemotherapy · 2014 · 29 citations

Can Neutrophil‐to‐Lymphocyte Ratio, Monocyte‐to‐Lymphocyte Ratio, and Platelet‐to‐Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?

Şerife Solmaz, Celal Acar, Aybüke Olgun et al. · Clinical Transplantation · 2018 · 26 citations

Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?

Şerife Solmaz, Özcan Uzun, Celal Acar et al. · Journal of Laboratory Physicians · 2018 · 17 citations · Full text

Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities

Ömür Gökmen Sevindik, Zeynep Gülsüm Güç, Selda Kahraman et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 13 citations

Hematological Malignancy, Prognostic Biomarkers, Surrogate Biomarker +15

Renal and Neurological Response with Eculizumab in a Patient with Transplant Associated Thrombotic Microangiopathy after Allogeneic Hematopoietic Progenitor Cell Transplantation

Ömür Gökmen Sevindik, İnci Alacacıoğlu, Abdullah Katgı et al. · Case Reports in Hematology · 2015 · 11 citations · Full text

Cell Therapy, Transplantation-associated Thrombotic Microangiopathy, Transplantation Medicine +17